{"id":5372,"date":"2022-10-23T14:03:00","date_gmt":"2022-10-23T13:03:00","guid":{"rendered":"https:\/\/catapult.org.uk\/?post_type=case_study&p=5372"},"modified":"2023-08-21T13:05:32","modified_gmt":"2023-08-21T12:05:32","slug":"transforming-uk-medical-imaging","status":"publish","type":"case_study","link":"https:\/\/catapult.org.uk\/our-work\/case-studies\/transforming-uk-medical-imaging\/","title":{"rendered":"Transforming UK medical imaging"},"content":{"rendered":"\n
<\/div>\n\n\n\n
\n
<\/div>\n\n\n\n
\n

Transforming UK medical imaging<\/h1>\n\n\n\n
<\/div>\n\n\n
\n
\"\"<\/figure><\/div>\n\n
\n 2019: \n <\/span>\n\n \n\n
\n Integrated regional imaging services into Medicines Discovery Catapult\n <\/div> <\/div>\n\n
<\/div>\n\n <\/div>
\n 2021:\n <\/span>\n\n \n\n
\n Established UK PET Network with leading academic centres of excellence\n <\/div> <\/div>\n\n
<\/div>\n\n <\/div>
\n 2021:\n <\/span>\n\n \n\n
\n Relaunched radiochemistry at the Wolfson Molecular Imaging Centre (WMIC)\n <\/div> <\/div>\n\n
<\/div> \n\n <\/div>
\n 2022:\n <\/span>\n\n \n\n
\n National leadership of industry-academic PET platform\n <\/div> <\/div>\n\n
<\/div>\n\n <\/div>\n\n <\/div> \n\n <\/div>\n\n\n
<\/div>\n\n\n\n
\n
\n

The Medicines Discovery Catapult is working to ensure the UK remains a world leader in Positron Emission Tomography (PET) Imaging, a data-rich non-invasive imaging modality that offers huge potential across the life sciences and is highly amenable to advances in AI.<\/p>\n\n\n\n

In April 2019, The Catapult integrated in-vivo<\/em> imaging services into its pre-clinical portfolio. It promoted and drove adoption of these advanced techniques through collaborative research programmes across a range of disease areas, accelerating drug R&D for UK SMEs. <\/p>\n\n\n\n

The Catapult\u2019s contribution of PET Imaging expertise and infrastructure has supported two of these UK SMEs in securing over \u00a312.5 million of private investment, with another obtaining a $360 million licensing deal for one of their drug candidates.<\/p>\n<\/div>\n\n\n\n

\n

In 2021 the Catapult created the UK PET Network with leading academic centres of excellence. The network has a clear seven-year plan to leverage UK innovation, expertise, and infrastructure to keep the UK at the leading edge of this important and valuable technology. This has led to the creation of a multimillion pound national PET transaction platform co-supported by industry and UK Research & Innovation (UKRI).<\/p>\n\n\n\n

Adding to these PET Imaging capabilities, the Catapult relaunched radiochemistry at Manchester\u2019s Wolfson Molecular Imaging Centre (WMIC) in August 2021. WMIC houses a multi-million-pound cyclotron that allows the Medicines Discovery Catapult to supply hard-to-make radiochemicals to drug discovery biotechs and academic innovators – increasing the UK\u2019s potential to discover new and better therapies for patients faster.<\/p>\n<\/div>\n<\/div>\n\n\n\n

<\/div>\n\n\n\n
<\/div>\n\n\n\n
<\/div>\n\n\n\n
\"\"<\/figure>\n\n\n\n

<\/p>\n<\/div>\n\n\n\n

<\/div>\n<\/div>\n\n\n\n
\n
<\/div>\n\n\n\n
<\/div>\n<\/div>\n\n\n\n
<\/div>\n\n\n\n
<\/div>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

The Medicines Discovery Catapult is working to ensure the UK remains a world leader in Positron Emission Tomography (PET) Imaging, a data-rich non-invasive imaging modality that offers huge potential across the life sciences and is highly amenable to advances in AI.<\/p>\n","protected":false},"featured_media":5373,"template":"","meta":{"_external_link_checkbox":false,"_external_link":"","_event_date":"","_featured_case_study":false},"categories":[10],"tags":[61,63],"class_list":["post-5372","case_study","type-case_study","status-publish","has-post-thumbnail","hentry","category-medicines-discovery","tag-catapult-highlights","tag-leverage"],"yoast_head":"\nTransforming UK medical imaging - The Catapult Network<\/title>\n<meta name=\"description\" content=\"The Medicines Discovery Catapult is working to ensure the UK remains a world leader in Positron Emission Tomography (PET) Imaging, a data-rich non-invasive imaging modality that offers huge potential across the life sciences and is highly amenable to advances in AI.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/catapult.org.uk\/our-work\/case-studies\/transforming-uk-medical-imaging\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Transforming UK medical imaging - The Catapult Network\" \/>\n<meta property=\"og:description\" content=\"The Medicines Discovery Catapult is working to ensure the UK remains a world leader in Positron Emission Tomography (PET) Imaging, a data-rich non-invasive imaging modality that offers huge potential across the life sciences and is highly amenable to advances in AI.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/catapult.org.uk\/our-work\/case-studies\/transforming-uk-medical-imaging\/\" \/>\n<meta property=\"og:site_name\" content=\"The Catapult Network\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-21T12:05:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/catapult.org.uk\/wp-content\/uploads\/2022\/08\/120A6200-scaledMDCPET.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@Catapult_UK\" \/>\n<meta name=\"twitter:label1\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/catapult.org.uk\/our-work\/case-studies\/transforming-uk-medical-imaging\/\",\"url\":\"https:\/\/catapult.org.uk\/our-work\/case-studies\/transforming-uk-medical-imaging\/\",\"name\":\"Transforming UK medical imaging - The Catapult Network\",\"isPartOf\":{\"@id\":\"https:\/\/catapult.org.uk\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/catapult.org.uk\/our-work\/case-studies\/transforming-uk-medical-imaging\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/catapult.org.uk\/our-work\/case-studies\/transforming-uk-medical-imaging\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/catapult.org.uk\/wp-content\/uploads\/2022\/08\/120A6200-scaledMDCPET.jpg\",\"datePublished\":\"2022-10-23T13:03:00+00:00\",\"dateModified\":\"2023-08-21T12:05:32+00:00\",\"description\":\"The Medicines Discovery Catapult is working to ensure the UK remains a world leader in Positron Emission Tomography (PET) Imaging, a data-rich non-invasive imaging modality that offers huge potential across the life sciences and is highly amenable to advances in AI.\",\"breadcrumb\":{\"@id\":\"https:\/\/catapult.org.uk\/our-work\/case-studies\/transforming-uk-medical-imaging\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/catapult.org.uk\/our-work\/case-studies\/transforming-uk-medical-imaging\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/catapult.org.uk\/our-work\/case-studies\/transforming-uk-medical-imaging\/#primaryimage\",\"url\":\"https:\/\/catapult.org.uk\/wp-content\/uploads\/2022\/08\/120A6200-scaledMDCPET.jpg\",\"contentUrl\":\"https:\/\/catapult.org.uk\/wp-content\/uploads\/2022\/08\/120A6200-scaledMDCPET.jpg\",\"width\":2560,\"height\":1707,\"caption\":\"Medicines Discovery Catapult Hero Image\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/catapult.org.uk\/our-work\/case-studies\/transforming-uk-medical-imaging\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/catapult.org.uk\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Case Studies\",\"item\":\"https:\/\/catapult.org.uk\/our-work\/case-studies\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Transforming UK medical imaging\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/catapult.org.uk\/#website\",\"url\":\"https:\/\/catapult.org.uk\/\",\"name\":\"The Catapult Network\",\"description\":\"The Innovate UK Catapult Network\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/catapult.org.uk\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Transforming UK medical imaging - The Catapult Network","description":"The Medicines Discovery Catapult is working to ensure the UK remains a world leader in Positron Emission Tomography (PET) Imaging, a data-rich non-invasive imaging modality that offers huge potential across the life sciences and is highly amenable to advances in AI.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/catapult.org.uk\/our-work\/case-studies\/transforming-uk-medical-imaging\/","og_locale":"en_GB","og_type":"article","og_title":"Transforming UK medical imaging - The Catapult Network","og_description":"The Medicines Discovery Catapult is working to ensure the UK remains a world leader in Positron Emission Tomography (PET) Imaging, a data-rich non-invasive imaging modality that offers huge potential across the life sciences and is highly amenable to advances in AI.","og_url":"https:\/\/catapult.org.uk\/our-work\/case-studies\/transforming-uk-medical-imaging\/","og_site_name":"The Catapult Network","article_modified_time":"2023-08-21T12:05:32+00:00","og_image":[{"width":2560,"height":1707,"url":"https:\/\/catapult.org.uk\/wp-content\/uploads\/2022\/08\/120A6200-scaledMDCPET.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@Catapult_UK","twitter_misc":{"Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/catapult.org.uk\/our-work\/case-studies\/transforming-uk-medical-imaging\/","url":"https:\/\/catapult.org.uk\/our-work\/case-studies\/transforming-uk-medical-imaging\/","name":"Transforming UK medical imaging - The Catapult Network","isPartOf":{"@id":"https:\/\/catapult.org.uk\/#website"},"primaryImageOfPage":{"@id":"https:\/\/catapult.org.uk\/our-work\/case-studies\/transforming-uk-medical-imaging\/#primaryimage"},"image":{"@id":"https:\/\/catapult.org.uk\/our-work\/case-studies\/transforming-uk-medical-imaging\/#primaryimage"},"thumbnailUrl":"https:\/\/catapult.org.uk\/wp-content\/uploads\/2022\/08\/120A6200-scaledMDCPET.jpg","datePublished":"2022-10-23T13:03:00+00:00","dateModified":"2023-08-21T12:05:32+00:00","description":"The Medicines Discovery Catapult is working to ensure the UK remains a world leader in Positron Emission Tomography (PET) Imaging, a data-rich non-invasive imaging modality that offers huge potential across the life sciences and is highly amenable to advances in AI.","breadcrumb":{"@id":"https:\/\/catapult.org.uk\/our-work\/case-studies\/transforming-uk-medical-imaging\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/catapult.org.uk\/our-work\/case-studies\/transforming-uk-medical-imaging\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/catapult.org.uk\/our-work\/case-studies\/transforming-uk-medical-imaging\/#primaryimage","url":"https:\/\/catapult.org.uk\/wp-content\/uploads\/2022\/08\/120A6200-scaledMDCPET.jpg","contentUrl":"https:\/\/catapult.org.uk\/wp-content\/uploads\/2022\/08\/120A6200-scaledMDCPET.jpg","width":2560,"height":1707,"caption":"Medicines Discovery Catapult Hero Image"},{"@type":"BreadcrumbList","@id":"https:\/\/catapult.org.uk\/our-work\/case-studies\/transforming-uk-medical-imaging\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/catapult.org.uk\/"},{"@type":"ListItem","position":2,"name":"Case Studies","item":"https:\/\/catapult.org.uk\/our-work\/case-studies\/"},{"@type":"ListItem","position":3,"name":"Transforming UK medical imaging"}]},{"@type":"WebSite","@id":"https:\/\/catapult.org.uk\/#website","url":"https:\/\/catapult.org.uk\/","name":"The Catapult Network","description":"The Innovate UK Catapult Network","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/catapult.org.uk\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"}]}},"_links":{"self":[{"href":"https:\/\/catapult.org.uk\/wp-json\/wp\/v2\/case_study\/5372","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/catapult.org.uk\/wp-json\/wp\/v2\/case_study"}],"about":[{"href":"https:\/\/catapult.org.uk\/wp-json\/wp\/v2\/types\/case_study"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/catapult.org.uk\/wp-json\/wp\/v2\/media\/5373"}],"wp:attachment":[{"href":"https:\/\/catapult.org.uk\/wp-json\/wp\/v2\/media?parent=5372"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/catapult.org.uk\/wp-json\/wp\/v2\/categories?post=5372"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/catapult.org.uk\/wp-json\/wp\/v2\/tags?post=5372"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}